+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bone Cancer Drug"

Bone Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Bone Cancer Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
Metastatic Bone Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Bone Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Global Oncolytic Virus Therapy Market Outlook to 2035 - Product Thumbnail Image

Global Oncolytic Virus Therapy Market Outlook to 2035

  • Report
  • April 2023
  • 144 Pages
  • Global
From
From
From
Bone Neoplasms - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bone Neoplasms - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Bone Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Metastatic Bone Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Global Bone Cancer Drugs Market 2021-2025 - Product Thumbnail Image

Global Bone Cancer Drugs Market 2021-2025

  • Report
  • June 2021
  • 120 Pages
  • Global
From
US Bone Cancer Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Bone Cancer Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
Loading Indicator

Bone cancer is a type of cancer that affects the cells of the bones. It is a rare form of cancer, but can be very aggressive and difficult to treat. Oncology drugs are used to treat bone cancer, and can include chemotherapy, radiation therapy, and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while radiation therapy is used to shrink tumors. Targeted therapy drugs are designed to target specific molecules in cancer cells, and can be used in combination with other treatments. The bone cancer drug market is a subset of the larger oncology drug market. It is a rapidly growing market, driven by the increasing prevalence of bone cancer and the development of new treatments. Companies in the bone cancer drug market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more